Correction: Metabolomics profiling for identification of novel potential markers in early prediction of preeclampsia (PLoS ONE (2014) 9, 5 (e98540) DOI:10.1371/journal.pone.0098540);Metabolomics profiling for identification of novel potential markers in early prediction of preeclampsia

PLoS ONE

Volumn 9, Issue 5, 2014, Pages

  Kuc, Sylwia ^a   Koster, Maria P H ^a   Pennings, Jeroen L A ^b   Hankemeier, Thomas ^c,d   Berger, Ruud ^c,d   Harms, Amy C ^d   Dane, Adrie D ^d   Schielen, Peter C J I ^b   Visser, Gerard H A ^a   Vreeken, Rob J ^c,d  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

^c LEIDEN UNIVERSITY   (Netherlands)

^d LEIDEN UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ASPARAGINE; BIOLOGICAL MARKER; GLYCYLGLYCINE; TAURINE;

ADULT; ARTICLE; CASE CONTROL STUDY; CONTROLLED STUDY; EARLY ONSET PREECLAMPSIA; FEMALE; FIRST TRIMESTER PREGNANCY; HUMAN; LATE ONSET PREECLAMPSIA; MAJOR CLINICAL STUDY; MEAN ARTERIAL PRESSURE; METABOLITE; METABOLOMICS; PREDICTION; PREECLAMPSIA; BLOOD; GESTATIONAL AGE; MALE; PRE-ECLAMPSIA; PREGNANCY; PREGNANCY OUTCOME; PROCEDURES; PROGNOSIS; RECEIVER OPERATING CHARACTERISTIC; REPRODUCIBILITY; RISK FACTOR;

ADULT; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; FEMALE; GESTATIONAL AGE; HUMANS; MALE; METABOLOMICS; PRE-ECLAMPSIA; PREGNANCY; PREGNANCY OUTCOME; PROGNOSIS; REPRODUCIBILITY OF RESULTS; RISK FACTORS; ROC CURVE;

EID: 84902179618     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0106358     Document Type: Erratum

References (52)

1. (1988) Geographic variation in the incidence of hypertension in pregnancy. World Health Organization International Collaborative Study of Hypertensive Disorders of Pregnancy. Am J Obstet Gynecol 158(1):80-3.
2. Saftlas AF, Olson DR, Franks AL, Atrash HK, Pokras R (1990) Epidemiology of preeclampsia and eclampsia in the United States, 1979-1986. Am J Obstet Gynecol 163(2):460-5. (Pubitemid 20287609)
3. Roberts JM, Pearson GD, Cutler JA, Lindheimer MD (2003) Summary of the NHLBI Working Group on Research on Hypertension During Pregnancy. Hypertens Pregnancy 22(2):109-27. (Pubitemid 37521363)
4. Sibai B, Dekker G, Kupferminc M (2005) Pre-eclampsia. Lancet 26;365(9461):785-99.
5. Bellamy L, Casas JP, Hingorani AD, Williams DJ (2007) Pre-eclampsia and risk of cardiovascular disease and cancer in later life: systematic review and meta-analysis. BMJ 10;335(7627):974.
6. Brown MA, Lindheimer MD, de Swiet M, Van Assche A, Moutquin JM (2001) The classification and diagnosis of the hypertensive disorders of pregnancy: statement from the International Society for the Study of Hypertension in Pregnancy (ISSHP). Hypertens Pregnancy 20(1):9-14.
7. Redman CW, Sargent IL (2003) Pre-eclampsia, the placenta and the maternal systemic inflammatory response - a review. Placenta 24 Suppl A:S21-S27.
8. Borzychowski AM, Sargent IL, Redman CW (2006) Inflammation and preeclampsia. Semin Fetal Neonatal Med 11(5):309-16.
9. Redman CW, Sargent IL (2005) Latest advances in understanding preeclampsia. Science 10;308(5728):1592-4.
10. Roberts JM (1998) Endothelial dysfunction in preeclampsia. Semin Reprod Endocrinol 16(1):5-15.
11. Visser N, van Rijn BB, Rijkers GT, Franx A, Bruinse HW (2007) Inflammatory changes in preeclampsia: current understanding of the maternal innate and adaptive immune response. Obstet Gynecol Surv 62(3):191-201. (Pubitemid 46294788)
12. Zhang A, Sun H, Wang X (2012) Serum metabolomics as a novel diagnostic approach for disease: a systematic review. Anal Bioanal Chem 404(4):1239-45.
13. Kenny LC, Broadhurst DI, Dunn W, Brown M, North RA, et al. (2010) Robust early pregnancy prediction of later preeclampsia using metabolomic biomarkers. Hypertension 56(4):741-9.
14. Odibo AO, Goetzinger KR, Odibo L, Cahill AG, Macones GA, et al. (2011) First trimester prediction of preeclampsia using metabolomic biomarkers: a discovery phase study. Prenat Diagn 31(10):990-4.
15. Bahado-Singh RO, Akolekar R, Mandal R, Dong E, Xia J, et al. (2012) Metabolomics and first trimester prediction of early-onset preeclampsia. J Matern Fetal Neonatal Med 25(10):1840-7.
16. Bahado-Singh RO, Akolekar R, Mandal R, Dong E, Xia J, et al. (2013) First trimester metabolomic detection of late-onset preeclampsia. Am J Obstet Gynecol 208(1):58-7.
17. Steegers EA, von Dadelszen P, Duvekot JJ, Pijnenborg R (2010) Pre-eclampsia. Lancet 21;376(9741):631-44.
18. Huppertz B (2008) Placental origins of preeclampsia: challenging the current hypothesis. Hypertension 51(4):970-5.
19. Wouters MG, Boers GH, Blom HJ, Trijbels FJ, Thomas CM, et al. (1993) Hyperhomocysteinemia: a risk factor in women with unexplained recurrent early pregnancy loss. Fertil Steril 60(5):820-5.
20. Dekker GA, de Vries JI, Doelitzsch PM, Huijgens PC, von Blomberg BM, et al. (1995) Underlying disorders associated with severe early-onset preeclampsia. Am J Obstet Gynecol 173(4):1042-8.
21. Kupferminc MJ, Peaceman AM, Dollberg S, Socol ML (1999) Tumor necrosis factor-alpha is decreased in the umbilical cord plasma of patients with severe preeclampsia. Am J Perinatol 16(5):203-8. (Pubitemid 29488779)
22. Kaymaz C, Demir A, Bige O, Cagliyan E, Cimrin D, et al. (2011) Analysis of perinatal outcome by combination of first trimester maternal plasma homocysteine with uterine artery Doppler velocimetry. Prenat Diagn 31(13):1246-50.
23. Mao D, Che J, Li K, Han S, Yue Q, et al. (2010) Association of homocysteine, asymmetric dimethylarginine, and nitric oxide with preeclampsia. Arch Gynecol Obstet 282(4):371-5.
24. Savvidis A, Daniilidis A, Giannoulis C, Tantanasis T, Koiou K, et al. (2011) Correlation between asymmetric dimethylarginine maternal plasma levels and preeclampsia. Clin Exp Obstet Gynecol 38(2):134-6.
25. Imig JD (2012) Epoxides and soluble epoxide hydrolase in cardiovascular physiology. Physiol Rev 92(1):101-30.
26. Funk CD (2011) Prostaglandins and leukotrienes: advances in eicosanoid biology. Science 30;294(5548):1871-5.
27. Robinson HP, Fleming JE (1975) A critical evaluation of sonar "crown-rump length" measurements. Br J Obstet Gynaecol 82(9):702-10.
28. Noga MJ, Dane A, Shi S, Attali A, van Aken H, et al. (2012) Metabolomics of cerebrospinal fluid reveals changes in the central nervous system metabolism in a rat model of multiple sclerosis. Metabolomics 8(2):253-63.
29. van der Kloet FM, Bobeldijk I, Verheij ER, Jellema RH (2009) Analytical error reduction using single point calibration for accurate and precise metabolomic phenotyping. J Proteome Res 8(11):5132-41.
30. Strassburg K, Huijbrechts AM, Kortekaas KA, Lindeman JH, Pedersen TL, et al. (2012) Quantitative profiling of oxylipins through comprehensive LC-MS/MS analysis: application in cardiac surgery. Anal Bioanal Chem 404(5):1413-26.
31. Cuckle HS, Wald N (2000) Principles of screening, tests using single markers. In: Wald NJ, Leck I, eds. Antenatal and Neonatal Screening. 2nd ed. Oxford: Oxford University Press; 3-22.
32. Kuc S, Koster MP, Franx A, Schielen PC, Visser GH (2013) Maternal characteristics, mean arterial pressure and serum markers in early prediction of preeclampsia. PLoS One 8(5):e63546.
33. Schoengold DM, de Fiore RH, Parlett RC (1978) Free amino acids in plasma throughout pregnancy. Am J Obstet Gynecol 1;131(5):490-9.
34. Cetin I, Corbetta C, Sereni LP, Marconi AM, Bozzetti P, et al. (1990) Umbilical amino acid concentrations in normal and growth-retarded fetuses sampled in utero by cordocentesis. Am J Obstet Gynecol 162(1):253-61. (Pubitemid 20055461)
35. Economides DL, Nicolaides KH, Gahl WA, Bernardini I, Evans MI (1989) Plasma amino acids in appropriate- and small-for-gestational-age fetuses. Am J Obstet Gynecol 161(5):1219-27. (Pubitemid 20007686)
36. Glew RH, Melah G, El-Nafaty AI, Brandt Y, Morris D, et al. (2004) Plasma and urinary free amino acid concentrations in preeclamptic women in northern Nigeria. Clin Chim Acta 342(1-2):179-85. (Pubitemid 38352927)
37. Evans RW, Powers RW, Ness RB, Cropcho LJ, Daftary AR, et al. (2003) Maternal and fetal amino acid concentrations and fetal outcomes during preeclampsia. Reproduction 125(6):785-90. (Pubitemid 36722546)
38. Wojcik OP, Koenig KL, Zeleniuch-Jacquotte A, Costa M, Chen Y (2010) The potential protective effects of taurine on coronary heart disease. Atherosclerosis 208(1):19-25.
39. Philipps AF, Holzman IR, Teng C, Battaglia FC (1978) Tissue concentrations of free amino acids in term human placentas. Am J Obstet Gynecol 15;131(8):881-7.
40. Desforges M, Parsons L, Westwood M, Sibley CP, Greenwood SL (2013) Taurine transport in human placental trophoblast is important for regulation of cell differentiation and survival. Cell Death Dis 4:e559.
41. Dawson R Jr, Liu S, Jung B, Messina S, Eppler B (2000) Effects of high salt diets and taurine on the development of hypertension in the stroke-prone spontaneously hypertensive rat. Amino Acids 19(3-4):643-65.
42. Horie R, Yamori Y, Nara Y, Sawamura M, Mano M (1987) Effects of sulphur amino acids on the development of hypertension and atherosclerosis in stroke-prone spontaneously hypertensive rats. J Hypertens Suppl 5(5):S223-S225.
43. Meldrum MJ, Tu R, Patterson T, Dawson R Jr, Petty T (1994) The effect of taurine on blood pressure, and urinary sodium, potassium and calcium excretion. Adv Exp Med Biol 359:207-15. (Pubitemid 24375551)
44. Jackson AA, Dunn RL, Marchand MC, Langley-Evans SC (2002) Increased systolic blood pressure in rats induced by a maternal low-protein diet is reversed by dietary supplementation with glycine. Clin Sci (Lond) 103(6):633-9. (Pubitemid 36005716)
45. Bagley PJ, Stipanuk MH (1995) Rats fed a low protein diet supplemented with sulfur amino acids have increased cysteine dioxygenase activity and increased taurine production in hepatocytes. J Nutr 125(4):933-40.
46. Lipton SA, Kim WK, Choi YB, Kumar S, D'Emilia DM, et al. (1997) Neurotoxicity associated with dual actions of homocysteine at the N-methyl-D-aspartate receptor. Proc Natl Acad Sci U S A 27;94(11):5923-8.
47. Ingec M, Borekci B, Kadanali S (2005) Elevated plasma homocysteine concentrations in severe preeclampsia and eclampsia. Tohoku J Exp Med 206(3):225-31. (Pubitemid 40895026)
48. Mao D, Che J, Li K, Han S, Yue Q, et al. (2010) Association of homocysteine, asymmetric dimethylarginine, and nitric oxide with preeclampsia. Arch Gynecol Obstet 282(4):371-5.
49. Makedos G, Papanicolaou A, Hitoglou A, Kalogiannidis I, Makedos A, et al. (2007) Homocysteine, folic acid and B12 serum levels in pregnancy complicated with preeclampsia. Arch Gynecol Obstet 275(2):121-4. (Pubitemid 46360641)
50. Khosrowbeygi A, Ahmadvand H (2011) Circulating levels of homocysteine in preeclamptic women. Bangladesh Med Res Counc Bull 37(3):106-9.
51. Liesenfeld D, Habermann N, Owen R, Scalbert A, Ulrich C (2013) Review of mass spectrometry-based metabolomics in cancer research. Cancer Epidemiol Biomarkers Prev 22(12);2182-201.
52. Leichtle A, Dufour J, Fiedler G (2013) Potentials and pitfalls of clinical peptidomics and metabolomics. Swiss Med Wkly 6;143:w13801.